Castleview Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Buy |
1,480
+186
| +14% | +$75.4K | 0.39% | 60 |
|
|
2025
Q1 | $644K | Sell |
1,294
-151
| -10% | -$75.1K | 0.44% | 58 |
|
|
2024
Q4 | $755K | Sell |
1,445
-211
| -13% | -$110K | 0.41% | 59 |
|
|
2024
Q3 | $1.02M | Buy |
1,656
+36
| +2% | +$22.3K | 0.59% | 33 |
|
|
2024
Q2 | $896K | Buy |
1,620
+186
| +13% | +$103K | 0.51% | 42 |
|
|
2024
Q1 | $833K | Buy |
1,434
+441
| +44% | +$256K | 0.47% | 51 |
|
|
2023
Q4 | $527K | Buy |
993
+3
| +0.3% | +$1.59K | 0.37% | 59 |
|
|
2023
Q3 | $501K | Sell |
990
-2
| -0.2% | -$1.01K | 0.46% | 44 |
|
|
2023
Q2 | $518K | Sell |
992
-3
| -0.3% | -$1.57K | 0.47% | 40 |
|
|
2023
Q1 | $573K | Sell |
995
-8
| -0.8% | -$4.61K | 0.51% | 45 |
|
|
2022
Q4 | $552K | Buy |
1,003
+570
| +132% | +$314K | 0.54% | 44 |
|
|
2022
Q3 | $220K | Sell |
433
-1,112
| -72% | -$565K | 0.21% | 99 |
|
|
2022
Q2 | $200K | Buy |
1,545
+1,112
| +257% | +$144K | 0.16% | 139 |
|
|
2022
Q1 | $255K | Sell |
433
-288,481
| -100% | -$170M | 0.16% | 132 |
|
|
2021
Q4 | $433 | Buy |
+288,914
| New | +$433 | ﹤0.01% | 550 |
|
|
2021
Q2 | $256K | Buy |
+507
| New | +$256K | 0.11% | 192 |
|
|
2018
Q1 | $201K | Buy |
+972
| New | +$201K | 0.17% | 109 |
|